General Healthcare News

Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...

This story from GE Reports was originally published during RSNA last year to help promote their new mammography equipment and referenced the good work being done at Gustave Roussy Cancer Center in a southern suburb of Paris.  But same day...

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...

Carlsbad, CA – January 11, 2017 – Applied Spectral Imaging (ASI) announced today that its GenASIsTM  applications comply with CE-IVD requirements under the European Directive on In Vitro Diagnostic Medical Devices, for automated analysis...

Last month a joint consensus statement developed by ASCO, the Association for Molecular Pathology (AMP), and the College of American Pathologists (CAP) on standardizing the interpretation and reporting of sequence variants in cancer was...

Fifth Annual Digital Pathology Transforming Medicine in a Digital Age February 20-22, 2017   |   Moscone North Convention Center   |   San Francisco, CA Part of the 24th Annual Molecular Medicine...